Anti-Inflammatory Effects of OxPAPC Involve Endothelial Cell–Mediated Generation of LXA4

Abstract

This is the first demonstration that inflammation- and injury-associated phospholipid oxidation triggers production of anti-inflammatory and proresolution molecules, such as LXA4. This lipid mediator switch represents a novel mechanism of OxPAPC-assisted recovery of inflamed lung endothelium.